Verona Pharma plc buy Wells Fargo & Company
Start price
20.06.25
/
50%
€0.51
Target price
20.06.26
€119.87
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 20.06.26. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Verona Pharma plc | - | - |
| iShares Core DAX® | 0.444% | 3.030% |
| iShares Nasdaq 100 | 3.819% | 4.073% |
| iShares Nikkei 225® | 1.148% | 6.904% |
| iShares S&P 500 | 2.371% | 2.677% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) had its price target raised by analysts at Wells Fargo & Company from $107.00 to $138.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat